Background: Cognitive impairment (CI) is common in people with multiple sclerosis (pwMS). The assessment of CI is based on neuropsychological tests and accurate anamnesis, involving the patients and caregivers (CG). This study aimed to assess the complex interplay between self-perception of CI, objective CI and the brain atrophy of MS patients, also exploring the possible differences with CI evaluated by caregivers. Methods: Relapsing pwMS were enrolled in this study. Subjects underwent neuropsychological examination using the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of self-reported cognitive status using the patient-version of the Multiple Sclerosis Neuropsychological Questionnaire (p-MSNQ). Depression and...
BACKGROUND AND PURPOSE Cognitive impairment (CI) is an important component of multiple sclerosis (M...
Background: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Background: Cognitive impairment (CI) is common in people with multiple sclerosis (pwMS). The assess...
Background: The relationship between cognitive assessment results in multiple sclerosis (MS) and per...
BACKGROUND Neurologists' perceptions of the presence of cognitive impairment (CI) in people with ...
Background Several correlations between cognitive impairment (CI), radiologic markers and cognitive ...
Introduction Research indicates that cognitive impairment in multiple sclerosis (MS) may occur in ap...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Background and Purpose: We aimed to estimate the prevalence of perceived cognitive impairment (PCI) ...
Background: The principal biomarker of neurodegeneration in multiple sclerosis (MS) is believed to b...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Ten people with multiple sclerosis (MS) who felt they had cognitive difficulties because of their MS...
This work was supported by FISM - Fondazione Italiana Sclerosi Multipla (www.aism.it) - Cod. 2009/R/...
Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis. It rema...
BACKGROUND AND PURPOSE Cognitive impairment (CI) is an important component of multiple sclerosis (M...
Background: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Background: Cognitive impairment (CI) is common in people with multiple sclerosis (pwMS). The assess...
Background: The relationship between cognitive assessment results in multiple sclerosis (MS) and per...
BACKGROUND Neurologists' perceptions of the presence of cognitive impairment (CI) in people with ...
Background Several correlations between cognitive impairment (CI), radiologic markers and cognitive ...
Introduction Research indicates that cognitive impairment in multiple sclerosis (MS) may occur in ap...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
Background and Purpose: We aimed to estimate the prevalence of perceived cognitive impairment (PCI) ...
Background: The principal biomarker of neurodegeneration in multiple sclerosis (MS) is believed to b...
Background: Cognitive dysfunction appears all through the course of multiple sclerosis (MS). Mild an...
Ten people with multiple sclerosis (MS) who felt they had cognitive difficulties because of their MS...
This work was supported by FISM - Fondazione Italiana Sclerosi Multipla (www.aism.it) - Cod. 2009/R/...
Cognitive impairment has been reported at all phases and all subtypes of multiple sclerosis. It rema...
BACKGROUND AND PURPOSE Cognitive impairment (CI) is an important component of multiple sclerosis (M...
Background: Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...